Biotech | November 30, 2021
Thermo Fisher Scientific’s new CRISPR Genome editing protein
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
Since its inception, the company has either acquired or taken a majority stake in five companies
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The AI-infused solution enables radiologists by fast triaging abnormalities in X-ray, annotating and automatic report generation with significantly improved performance
The event will include an exhibition and sector-wise sessions for two days with participation by officials from the Ministry of Commerce, export promotion councils and members of the industry
Godrej and Boyce and Isgec Engineering have confirmed receiving the orders
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
The vaccine is designed to neutralise the virus in the nostril itself and prevent it from penetrating deep down into the respiratory tract
Subscribe To Our Newsletter & Stay Updated
